サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1790235

感染管理の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

Infection Control Market Size, Share & Trends Analysis Report By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.53円
感染管理の市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2025年07月04日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

感染管理市場の概要

世界の感染制御市場規模は2024年に523億8,000万米ドルと推定され、2025～2030年にかけてCAGR 6.1%で成長し、2030年には742億1,000万米ドルに達すると予測されます。この市場を牽引しているのは、主に感染予防を必要とする外科手術や臨床処置の増加です。

感染管理の技術的進歩により、ヘルスケア提供者の感染予防・管理能力は大幅に向上しています。自動消毒システム、UVライト技術、抗菌性表面コーティング、高度空気濾過システムなどの技術革新は、HAIを最大30%削減する効果を実証しており、市場成長に寄与すると期待されています。滅菌サービスのアウトソーシングの増加や先進的滅菌ソリューションの導入は、感染制御市場の成長にさらに貢献しています。重要な成長要因の1つは、感染予防を高度に徹底するための政府の取り組みが増加していることです。政府機関は、世界の認識と効率的な予防対策を促進するためのガイドラインの発行にますます関与しており、予測期間を通じて市場成長に貢献すると期待されています。例えば、世界保健機関（WHO）は、医療におけるパンデミックや流行性急性呼吸器疾患の予防と制御のためのガイドラインを発行しています。このガイドラインは、手指衛生や個人防護具の使用といった標準的な予防策から、消毒や滅菌に関するガイドラインまで多岐にわたります。

国立医療図書館が2024年5月に発表した紙製によると、急性呼吸器感染症（ARI）は世界的に大きな健康負担となっており、年間約425万人が死亡しています。これらの感染症は毎年数百万人の外来受診につながり、特に高齢者、幼児、喘息や心臓病などの慢性疾患を持つ人などのハイリスクグループに影響を及ぼしています。

肺炎などの疾患や血流感染、尿路感染、手術部位感染、MRSAなどの感染症は、院内感染のほとんどを占めます。その他の主要ヘルスケア関連感染症（HAI）には、カテーテル関連尿路感染症、人工呼吸器関連肺炎、カテーテル関連血流感染症などがあります。HAIは患者の回復に影響を与えるため、世界的に死亡率に大きな影響を与えています。2023年4月のNIHの記事によると、HAIは病院における最も一般的な副作用であり、深刻な健康リスク、罹患率と死亡率の増加、患者・家族ヘルスケアシステムのコスト増につながっています。HAIは米国では入院患者の約3.2%、EUでは6.5%に影響を及ぼしており、世界の蔓延率はさらに高くなると予想されています。このため、効果的な感染予防・管理ソリューションの必要性が高まっています。

WHOが発表した院内感染防止に関する実践ガイドによると、外科感染症による入院期間の増加は約8日間でした。このような入院期間の長期化は、入院期間中に発生する総費用に大きく寄与することが予測されるため、感染予防策を採用することの臨床的緊急性が高まっています。入院期間の長期化は、後天性感染症の治療にリソースを過剰に使用するため、病院やヘルスケア支払者にとっても不経済であると推測されます。このような追加コストは、主に薬剤の使用量の増加、追加の診断検査、検査機器によって発生し、資源配分の不均衡を生み出しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 感染管理市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/付随市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 感染管理市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析
  • 感染管理市場：パイプライン分析

第4章 感染管理市場：タイプ別、推定・動向分析

  • タイプセグメントダッシュボード
  • 感染管理市場：タイプ変動分析
  • 世界の感染制御市場規模と動向分析（タイプ別、2018～2030年）
  • 装置
    • 消毒剤
    • 滅菌装置
    • その他
  • サービス
    • 契約不妊手術
    • 感染性廃棄物の処分
  • 消耗品
    • 感染性廃棄物の処分
    • 消毒剤
    • 滅菌消耗品
    • 個人用保護具
    • その他

第5章 感染管理市場：最終用途別、推定・動向分析

  • 最終用途セグメントダッシュボード
  • 感染管理市場：最終用途変動分析
  • 世界の感染制御市場規模と動向分析（最終用途別、2018～2030年）
  • 病院
  • 医療機器企業
  • 臨床検査室
  • 製薬ラボ
  • その他

第6章 感染管理市場：地域別、推定・動向分析

  • 地域別市場ダッシュボード
  • 地域別市場シェア分析、2024年と2030年
  • 地域別感染管理市場：主要ポイント
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業のヒートマップ分析、2024年
  • 企業プロファイル
    • 3M
    • Belimed AG
    • O& M Halyard or its affiliates.
    • GETINGE AB（publ）Corporate
    • ASP
    • MATACHANA
    • Sterigenics US, LLC-A Sotera Health company
    • MMM Group
    • Medivators Inc.
    • STERIS.
    • Midmark Corporation
    • W& H
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global infection control market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global infection control market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America infection control market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America infection control market, by type, 2018 - 2030 (USD Million)
  • Table 7 North America infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. infection control market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada infection control market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico infection control market, by type, 2018 - 2030 (USD Million)
  • Table 13 Mexico infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Europe infection control market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe infection control market, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Germany infection control market, by type, 2018 - 2030 (USD Million)
  • Table 18 Germany infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK infection control market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 21 France infection control market, by type, 2018 - 2030 (USD Million)
  • Table 22 France infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Italy infection control market, by type, 2018 - 2030 (USD Million)
  • Table 24 Italy infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Spain infection control market, by type, 2018 - 2030 (USD Million)
  • Table 26 Spain infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Denmark infection control market, by type, 2018 - 2030 (USD Million)
  • Table 28 Denmark infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Sweden infection control market, by type, 2018 - 2030 (USD Million)
  • Table 30 Sweden infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Norway infection control market, by type, 2018 - 2030 (USD Million)
  • Table 32 Norway infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific infection control market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific infection control market, by type, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 36 China infection control market, by type, 2018 - 2030 (USD Million)
  • Table 37 China infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Japan infection control market, by type, 2018 - 2030 (USD Million)
  • Table 39 Japan infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 40 India infection control market, by type, 2018 - 2030 (USD Million)
  • Table 41 India infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 42 South Korea infection control market, by type, 2018 - 2030 (USD Million)
  • Table 43 Australia infection control market, by type, 2018 - 2030 (USD Million)
  • Table 44 Thailand infection control market, by type, 2018 - 2030 (USD Million)
  • Table 45 Thailand infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Latin America infection control market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America infection control market, by type, 2018 - 2030 (USD Million)
  • Table 48 Latin America infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Brazil infection control market, by type, 2018 - 2030 (USD Million)
  • Table 50 Brazil infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Argentina infection control market, by type, 2018 - 2030 (USD Million)
  • Table 52 Argentina infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 53 MEA infection control market, by country, 2018 - 2030 (USD Million)
  • Table 54 MEA infection control market, by type, 2018 - 2030 (USD Million)
  • Table 55 MEA infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Africa infection control market, by type, 2018 - 2030 (USD Million)
  • Table 57 South Africa infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia infection control market, by type, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 60 UAE infection control market, by type, 2018 - 2030 (USD Million)
  • Table 61 UAE infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait infection control market, by type, 2018 - 2030 (USD Million)
  • Table 63 Kuwait infection control market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Infection control market: market outlook
  • Fig. 10 Infection control market competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Infection control market driver impact
  • Fig. 16 Infection control market restraint impact
  • Fig. 17 Infection control market strategic initiatives analysis
  • Fig. 18 Infection control market: Type movement analysis
  • Fig. 19 Infection control market: Type outlook and key takeaways
  • Fig. 20 Equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Disinfectors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Washers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Flushes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Endoscope reprocessors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Heat sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Low temperature sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Radiation sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Filtration sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Liquid sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Contract sterilization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Ethylene oxide Sterilization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 E-beam sterilization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Gamma sterilization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Infectious waste Disposal market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Infectious waste disposal market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Disinfectants market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Safety enhanced medical devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Sterilization consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Personal protective equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Infection control market: End use movement Analysis
  • Fig. 47 Infection control market: End use outlook and key takeaways
  • Fig. 48 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Medical device companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Pharmaceutical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Global infection control market: Regional movement analysis
  • Fig. 54 Global infection control market: Regional outlook and key takeaways
  • Fig. 55 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-822-0

Infection Control Market Summary

The global infection control market size was estimated at USD 52.38 billion in 2024, and is projected to reach USD 74.21 billion by 2030, growing at a CAGR of 6.1% from 2025 to 2030. The market is primarily driven by an increasing number of surgical & clinical procedures that require infection prevention.

Technological advancements in infection control have significantly enhanced the ability of healthcare providers to prevent and manage infections. Innovations such as automated disinfection systems, UV light technology, antimicrobial surface coatings, and advanced air filtration systems have demonstrated efficacy in reducing HAIs by up to 30% and is expected to contribute to the market growth. An increase in outsourcing sterilization services and the introduction of advanced sterilizing solutions are further contributing to the growth of the market for infection control. One of the important growth drivers is the increasing number of government initiatives to ensure highly intensive infection prevention. Government organizations are increasingly involved in issuing guidelines to promote awareness and efficient prevention measures globally, which is expected to contribute to market growth throughout the forecast period. For instance, the World Health Organization (WHO) has issued guidelines for preventing and controlling pandemic- and epidemic-prone acute respiratory diseases in healthcare. The guidelines range from standard precautions such as hand hygiene and usage of personal protective equipment to guidelines for disinfection and sterilization.

According to the article published by the National Library of Medicine in May 2024, Acute respiratory infections (ARIs) are a major global health burden, leading to around 4.25 million deaths annually. These infections lead to millions of outpatient visits each year, particularly affecting high-risk groups such as the elderly, young children, and individuals with chronic conditions such as asthma or heart disease.

Diseases such as pneumonia and infections such as bloodstream, urinary tract, surgical site, and MRSA constitute most hospital-acquired infections. Other major healthcare-associated infections (HAIs) include catheter-associated urinary tract infections, ventilator-associated pneumonia, and catheter-related bloodstream. One of the utmost concerns for the market is HAIs, which affect patient recovery; thereby, mortality rates are being significantly impacted globally. According to an article by NIH in April 2023, HAIs are the most common adverse effects in hospitals, leading to serious health risks, increased morbidity and mortality, and higher costs for patients, families, and healthcare systems. HAIs affect about 3.2% of hospitalized patients in the U.S. and 6.5% in the EU, with global prevalence expected to be even higher. This facilitates the need for effective infection prevention and control solutions.

According to a practical guide published by the WHO on preventing hospital-acquired infections, the increase in hospitalization duration with surgical infections was approximately eight days. These prolonged stays are predicted to significantly contribute to the overall costs incurred during the hospitalization period, thus, raising the clinical urgency for adopting infection prevention measures. It is presumed that prolonged hospital stay is also not economical for the hospitals and healthcare payers due to excessive usage of resources to treat the acquired infection. These additional costs are majorly generated through increased usage of drugs, additional diagnostic studies, and laboratory equipment, creating a resource allocation imbalance.

Global Infection Control Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the global infection control market on the basis of type, end use, and region:

  • Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Equipment
    • Disinfectors
    • Washers
    • Flushes
    • Endoscope Reprocessors
    • Sterilization Equipment
    • Heat Sterilization Equipment
    • Low Temperature Sterilization Equipment
    • Radiation Sterilization Equipment
    • Filtration Sterilization Equipment
    • Liquid Sterilization Equipment
    • Others
  • Services
    • Contract Sterilization
    • Ethylene Oxide Sterilization
    • E-beam Sterilization
    • Gamma Sterilization
    • Others
    • Infectious Waste Disposal
  • Consumables
    • Infectious Waste Disposal
    • Disinfectants
    • Sterilization Consumables
    • Safety enhanced medical devices
    • Personal Protective Equipment
    • Others
  • End Use Outlook (Revenue, USD Billion, 2018 - 2030)
  • Hospitals
  • Medical Device Companies
  • Clinical Laboratories
  • Pharmaceutical Laboratories
  • Others
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Infection Control Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Infection Control Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Infection Control Market: Pipeline Analysis

Chapter 4. Infection Control Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Infection Control Market: Type Movement Analysis
  • 4.3. Global Infection Control Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Equipment
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Disinfectors
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Washers
        • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Flushes
        • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Endoscope Reprocessors
        • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Sterilization Equipment
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.2. Heat sterilization equipment
        • 4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.3. Low Temperature Sterilization Equipment
        • 4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.4. Radiation Sterilization Equipment
        • 4.4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.5. Filtration Sterilization Equipment
        • 4.4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.6. Liquid Sterilization Equipment
        • 4.4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Contract Sterilization
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.2. Ethylene Oxide Sterilization
        • 4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.3. E-beam Sterilization
        • 4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.4. Gamma Sterilization
        • 4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.5. Others
        • 4.5.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Infectious Waste Disposal
  • 4.6. Consumables
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Infectious Waste Disposal
      • 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Disinfectants
      • 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Sterilization Consumables
      • 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.5. Personal Protective Equipment
      • 4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.6. Others
      • 4.6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Infection Control Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. Infection Control Market: End Use Movement Analysis
  • 5.3. Global Infection Control Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Medical Device Companies
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Clinical Laboratories
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Pharmaceutical Laboratories
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Infection Control Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Infection Control Market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Norway
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Argentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. 3M
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Belimed AG
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. O&M Halyard or its affiliates.
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. GETINGE AB (publ) Corporate
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. ASP
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. MATACHANA
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Sterigenics U.S., LLC - A Sotera Health company
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. MMM Group
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Medivators Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. STERIS.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Midmark Corporation.
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. W&H
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives